This is a news collection page for Canberra. Check this page for latest news headlines covering major stories, events from Canberra and surrounding ACT. Get breaking news faster than any other ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Catch up on all the biggest pharma news to hit the industry last month, spanning from new acquisitions, insights on the NHS ...
The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...
La decima giornata di Serie A conclude il suo secondo giorno con le sfide di Bergamo e Torino: Atalanta-Monza e Juventus-Parma. ATALANTA (3-4-2-1): Carnesecchi; Djimsiti, Hien, Kolasinac; Bellanova, ...
Independent Online, popularly known as IOL, is one of South Africa’s leading news and information websites bringing millions of readers breaking news and updates on Politics, Current Affairs ...
AutoNation faced a $0.21 per share impact from the CDK outage in July, contributing to a 9% decline in gross profit year over year. AutoNation, Inc. AN shares are trading lower after the company ...
The Cloud Development Kit (CDK) is an open source framework, developed by AWS, that allows developers to define cloud application infrastructure as code using programming languages such as Python, ...
A council plans on battling “the plague” of shopping trolleys dumped in its rivers and streets by hitting supermarkets harder in the pocket. A wildlife reserve visitor centre has been damaged ...
Cybersecurity researchers have disclosed a security flaw impacting Amazon Web Services (AWS) Cloud Development Kit (CDK) that could have resulted in an account takeover under specific circumstances.
UCB will advance its anti-tau antibody for Alzheimer’s disease solo after Roche and Genentech walked away from the asset known as bepranemab.
UCB granted Roche and its biotech unit Genentech an exclusive worldwide license to bepranemab, then called UCB0107, in 2020 as part of a deal worth around $2 billion in milestones. The agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback